Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 230, Issue 2, Pages 228-238
Publisher
Wiley
Online
2013-02-20
DOI
10.1002/path.4181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR
- (2012) Daniela Coltrini et al. ANGIOGENESIS
- Long Pentraxin 3/Tumor Necrosis Factor-Stimulated Gene-6 Interaction
- (2012) Daria Leali et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Fibroblast Growth Factors in Development and Cancer: Insights from the Mammary and Prostate Glands
- (2012) Kathryn Schwertfeger CURRENT DRUG TARGETS
- Anticancer molecules targeting fibroblast growth factor receptors
- (2012) Guang Liang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- Precursors of prostate cancer
- (2011) David G Bostwick et al. HISTOPATHOLOGY
- Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
- (2011) F. Dayyani et al. JNCI-Journal of the National Cancer Institute
- Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors
- (2011) D. Leali et al. MOLECULAR CANCER THERAPEUTICS
- Aberrant methylation of the 3q25 tumor suppressor genePTX3in human esophageal squamous cell carcinoma
- (2011) Jun-Xiong Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment
- (2010) Marco Tafani et al. CANCER SCIENCE
- Paths of FGFR-driven tumorigenesis
- (2010) Victor D. Acevedo et al. CELL CYCLE
- Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1
- (2010) R. Ronca et al. MOLECULAR CANCER THERAPEUTICS
- Basal epithelial stem cells are efficient targets for prostate cancer initiation
- (2010) D. A. Lawson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a Cell of Origin for Human Prostate Cancer
- (2010) A. S. Goldstein et al. SCIENCE
- Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
- (2009) D. Leali et al. CURRENT PHARMACEUTICAL DESIGN
- Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide
- (2009) Daria Leali et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- How Well Do Angiogenesis Inhibitors Work? Biomarkers of Response Prove Elusive
- (2009) Vicki Brower JNCI-Journal of the National Cancer Institute
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma
- (2009) Linda Ravenna et al. PROSTATE
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
- Prostate cancer
- (2008) Jan-Erik Damber et al. LANCET
- A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions
- (2008) Kumiko Maruyama-Takahashi et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More